Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT03855683
Other study ID # 15-061
Secondary ID
Status Suspended
Phase N/A
First received
Last updated
Start date March 6, 2019
Est. completion date February 2022

Study information

Verified date September 2020
Source Palo Alto University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to identify cognitive mechanisms that might facilitate treatment response for individuals experiencing depression and/or anxiety. The Stress, Anxiety, and Mood group helps individuals experiencing symptoms of stress, anxiety, and mood by providing concrete coping skills to regulate emotions, to let go of negative thoughts, and build courage to talk to others about tough topics. Groups meet for 8 weeks, with sessions lasting 90 minutes each. In addition to group therapy, you will be asked to complete some computerized and paper and pencil-based tasks.

If you are interested in learning more, please contact us at 650-417-2000 ext. 3642 or paloalto.study@gmail.com. All inquiries will be kept strictly confidential.


Description:

PRIMARY OBJECTIVES:

I. Identify specific patterns of executive function impairment that distinguish affective and cognitive symptoms in anxious and/or depressed patients.

II. Identify specific components of executive function that predict Unified Protocol treatment response. This will set up subsequent cognitive intervention studies targeting those components.

The phone screen includes a confidentiality statement explaining how their information will be kept confidential, demographic questions, and questions regarding the participants' medical and psychiatric history, and current psychological state. Responses to these questions will be used to determine if the individual meets inclusion criteria to engage in the study. If the participant meets study eligibility criteria, he/she will be invited to an informational session not exceeding two and a half hours at Dr. Warren's lab, which involves an explanation the project, informed consent, some questionnaires, and a diagnostic clinical interview. Also during the first visit, participants will be informed of the upcoming visits and the types of activities they will be asked to engage in for the purposes of this study. During a second visit, subjects will undergo cognitive testing designed to measure set shifting, working memory updating, cognitive inhibition, processing speed, general intelligence, and attentional control. These tests will be administered at Dr. Warren's lab and will not exceed two and a half hours. The remainder of the study visits will involve an 8-week, cognitive-behavioral group therapy titled "Unified Protocol," to take place at the Gronowski Clinic. Treatment groups will be facilitated by Dr. Warren and co-facilitated by trained graduate students selected by Dr. Warren.


Recruitment information / eligibility

Status Suspended
Enrollment 50
Est. completion date February 2022
Est. primary completion date February 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Normal color vision

- Ability to travel to Palo Alto University

- Experiencing symptoms of stress, anxiety, and/or depression

Study Design


Intervention

Behavioral:
Unified Protocol for The Treatment of Emotional Disorders
Unified Protocol (UP) is is an 8-week intervention designed to specifically benefit individuals who report co-occurring symptoms of anxiety, stress, and mood by providing them with psychoeducation regarding (mal)adaptive emotion regulation, as well as with skills for effectively responding to stress. UP is based on a cognitive-behavioral framework and uses cognitive and behavioral therapy techniques. Each session of UP group therapy is 90 minutes in duration. Sessions themselves generally include a review of homework and previously discussed concepts, introduction of new material, and in-session discussions/activities.

Locations

Country Name City State
United States Palo Alto University Los Altos California

Sponsors (1)

Lead Sponsor Collaborator
Palo Alto University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Level of depression as measured by the following questionnaire: Mood and Anxiety Symptom Questionnaire- Anhedonic Depression subscale The change from baseline and post-treatment, approximately 8 weeks after baseline
Primary Level of intolerance of uncertainty as measured by the following questionnaire: Intolerance of Uncertainty Questionnaire The change from baseline and post-treatment, approximately 8 weeks after baseline
Primary Level of rumination and reflection as measured by the following questionnaire: Rumination Reflection Questionnaire The change from baseline and post-treatment, approximately 8 weeks after baseline
Primary Level of anxious arousal as measured by the following questionnaire: Mood and Anxiety Symptom Questionnaire- Anxious Apprehension subscale The change from baseline and post-treatment, approximately 8 weeks after baseline
Primary Level of anxious apprehension as measured by the following questionnaire: Penn State Worry Questionnaire The change from baseline and post-treatment, approximately 8 weeks after baseline
Primary Level of alcohol use as measured by the following questionnaire: Alcohol Use Disorders Identification Test The change from baseline and post-treatment, approximately 8 weeks after baseline
Primary Level of positive and negative emotions as measured by the following questionnaire: The Positive and Negative Affect Schedule The change from baseline and post-treatment, approximately 8 weeks after baseline
Primary Level of behavioral regulation and metacognition as measured by the following questionnaire: Behavioral Regulation Index and Metacognition Index The change from baseline and post-treatment, approximately 8 weeks after baseline
Primary Level of trait mood as measured by the following questionnaire: Trait Meta-Mood Scale. The change from baseline and post-treatment, approximately 8 weeks after baseline
Primary Level of emotion regulation as measured by the following questionnaire: Emotion Regulation Questionnaire The change from baseline and post-treatment, approximately 8 weeks after baseline
Primary Level of mental imagery as measured by the following questionnaire: Questionnaire of Mental Imagery The change from baseline and post-treatment, approximately 8 weeks after baseline
Primary Level of cognitive functioning via neuropsychological testing session Objective assessment of cognitive strengths and weaknesses Baseline
See also
  Status Clinical Trial Phase
Completed NCT03535805 - Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Recruiting NCT05419934 - EMDR Therapy in Young Children, a Double-blinded Randomized Controlled Trial N/A
Active, not recruiting NCT04136054 - Better Sleep in Psychiatric Care - Anxiety and Affective Disorders N/A
Completed NCT04091139 - Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong Phase 2/Phase 3
Completed NCT04647318 - Physiological Response to Self-compassion Versus Relaxation N/A
Active, not recruiting NCT05114824 - Acceptability and Feasibility of an 8-week Online Mindfulness-Based Cognitive Therapy Program Among Undergraduate Students N/A
Recruiting NCT05843695 - Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety N/A
Completed NCT05078450 - Mood Lifters Online for Graduate Students and Young Professionals N/A
Not yet recruiting NCT06162624 - Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons N/A
Not yet recruiting NCT05747131 - Emotion Detectives In-Out: Feasibility and Efficacy of a Blended Version of the Unified Protocol for Children N/A
Not yet recruiting NCT05863637 - Intensive Short-Term Dynamic Psychotherapy (ISTDP) for Anxiety Diagnoses in a Primary Care Setting N/A
Not yet recruiting NCT05225701 - Efficacy of a Transdiagnostic Guided Internet-Delivered Intervention for Emotional, Trauma and Stress-Related Disorders. N/A
Completed NCT02579915 - Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders (AIM-PC) N/A
Recruiting NCT02376959 - Effect of Spiritist "Passe" Energy Therapy in Reducing Anxiety in Volunteers N/A
Recruiting NCT02186366 - Efficacy Study of Abdominal Massage Therapy to Treat Generalized Anxiety Disorder of Deficiency of Both Heart and Spleen Type N/A
Not yet recruiting NCT02126787 - Short-term, Intensive Psychodynamic Group Therapy Versus Cognitive-behavioral Group Therapy in the Day Treatment N/A
Withdrawn NCT01953042 - Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders N/A
Completed NCT02134730 - School-based Universal Prevention for Anxiety and Depression in Sweden: A Cluster-randomized Trial N/A
Completed NCT01333098 - Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders Phase 1/Phase 2